Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02094885Phase 4Completed
Phase 4, randomised, single-blind trial of porcine fibrin sealant in hemorrhage (2 arms), sponsored by Ethicon. Primary endpoint: Hemostasis at the Target Bleeding Site (TBS) at 10 Minutes Following the Completion of Treatment Application. Started Feb 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02094885.